Who qualifies for the Elanco K9 Advantix antitrust settlement?

The settlement covers consumers who purchased topical flea and tick products for dogs and cats containing imidacloprid, including Elanco's K9 Advantix II and Advantage II products, from a pet specialty retailer. The named pet specialty retailers in the case are Chewy, Petco, PetSmart, PetMed Express, and Tractor Supply (Petsense). The original Spradlin complaint described a nationwide class of purchasers, with state-law indirect-purchaser claims also brought under the antitrust laws of approximately 29 states and the District of Columbia. The exact class definition will be confirmed in the court-approved class notice once it is issued.

How much can I get from the Elanco settlement?

The total settlement fund is $9.275 million, contributed by Elanco Animal Health and the five pet retailer defendants. Per-claimant payouts have not been announced and will depend on how many class members file claims, what the court approves for attorneys' fees and administrative expenses, and how the court allocates the fund. Pet owners who purchased K9 Advantix II or Advantage II from one of the named retailers should watch for an official class notice with claim instructions in the coming months.

Which pet retailers are defendants in the Elanco settlement?

Five major pet specialty retailers were named alongside Elanco in the consolidated case: Chewy Inc., Petco Animal Supplies Store Inc., PetSmart LLC, PetMed Express Inc., and Petsense LLC (owned by Tractor Supply Co.). All five reached separate settlements in February and March 2026, alongside Elanco's own settlement contribution, for a combined total fund of $9.275 million.

What does Elanco have to do besides pay money?

According to The Indiana Lawyer reporting on the settlement, Elanco is barred from offering its exclusive discount on Advantix products for five years as part of the deal. This non-monetary relief is intended to give generic imidacloprid topical manufacturers a fair chance to compete for placement at pet specialty retailers. The practical effect for consumers, if generic alternatives reach store shelves as a result, could be lower prices on imidacloprid flea and tick treatments overall.

When will I be able to file a claim in the Elanco settlement?

No claim form has been published yet. Based on typical class action timelines, the official claim portal is most likely to open in late summer to fall 2026, with the claim deadline most likely landing late 2026 to early 2027. The expected steps are: preliminary approval motion (estimated May to July 2026), preliminary approval order (estimated summer to early fall 2026), class notice mailing or emailing 30 to 60 days after preliminary approval, the claim form opening on the official settlement website at the same time, a 90 to 180 day claim filing window, a final fairness hearing 4 to 6 months after preliminary approval, and payment distribution 30 to 90 days after final approval. First payments could realistically arrive in spring or summer 2027 in a clean scenario with no appeals.

Does the Elanco settlement cover dogs only or both dogs and cats?

Both. K9 Advantix II is the dog-only product. Advantage II is sold in both dog and cat formulations. The lawsuit and settlement cover both topical imidacloprid product lines, so cat owners who bought Advantage II for cats from one of the named pet specialty retailers are within the same alleged class as dog owners who bought K9 Advantix II or Advantage II for dogs.

Does the Elanco settlement cover online purchases at Chewy and PetMed Express, or only in-store purchases at Petco, PetSmart, and Tractor Supply?

Both online and in-store purchases are covered. All five retailer defendants are named in the consolidated case: Chewy (online), PetMed Express (online), Petco (in-store and online at Petco.com), PetSmart (in-store and online at PetSmart.com), and Tractor Supply / Petsense (in-store and online at TractorSupply.com). Pet owners who bought K9 Advantix II or Advantage II through any channel of any of the five named retailers are within the alleged class.

Is Seresto flea collar covered by the Elanco settlement?

Seresto is referenced in the complaint as part of the alleged bundling and rebate conduct -- Elanco allegedly offered exclusive Seresto discounts to pet retailers in exchange for those retailers refusing to stock generic imidacloprid flea and tick topicals. However, Seresto itself is not the class purchase that consumers are claiming on. The class purchase is K9 Advantix II and Advantage II topical imidacloprid flea and tick treatments.

Do I need receipts to file a claim in the Elanco K9 Advantix settlement?

Probably not for a basic claim. All five retailer defendants have substantial digital purchase records, especially Chewy and PetMed Express, which are online-first sellers that track customer purchases in detail. Most class members are likely to be able to file a claim without receipts and have the retailer's records verify the purchase. Pet owners who do have receipts (paper, email order confirmations, or in-app purchase histories) may qualify for a higher payment tier under the eventual court-approved plan of allocation. The exact proof requirements will be specified in the official claim form when it is published.

Elanco and Pet Retailers Reach $9.275M Antitrust Settlement Over K9 Advantix and Advantage Flea & Tick Pricing

Q: What was the Elanco K9 Advantix lawsuit about?

The lawsuit alleged that Elanco entered into verbal 'no generics' agreements with major pet specialty retailers, paying or rewarding those retailers in exchange for refusing to stock cheaper generic versions of imidacloprid topical flea and tick treatments. The lawsuit claimed Elanco controlled nearly 100 percent of the imidacloprid topical market and that these agreements kept generic alternatives like Tevra Brands' Activate II and Actispot II off pet specialty store shelves, forcing consumers to pay inflated prices for the brand-name Advantix and Advantage products. Generic competitors typically sold for roughly half the price of the brand-name versions. Elanco denies the allegations and is settling without admitting liability.

By Steve Levine

Elanco K9 Advantix Advantage pet flea tick antitrust class action settlement

Published: May 12, 2026

Status Settlement Reached — Notice Pending

Settlement Date March 2026 final retailer settlements followed Elanco's February 2026 settlement

Settlement Fund $9.275 Million total from Elanco + Chewy + Petco + PetSmart + PetMed Express + Tractor Supply/Petsense

Non-Monetary Relief 5-Year Discount Ban Elanco barred from offering its exclusive Advantix discount for five years

Estimated Claim Form Open Late Summer – Fall 2026 OCA estimate based on typical class action timelines — not an official date; subject to court schedule

Estimated Claim Deadline Late 2026 – Early 2027 typical 90 to 180 day claim window after class notice; controlled by court order

What Just Happened With the Elanco K9 Advantix Settlement?

Pet owners who bought K9 Advantix II or Advantage II flea and tick treatments from Chewy, Petco, PetSmart, PetMed Express, or Tractor Supply may soon receive notice of a class action settlement. Elanco Animal Health and the five pet specialty retailers have agreed to a combined $9.275 million settlement, ending nearly two years of antitrust litigation that alleged Elanco paid retailers to keep cheaper generic versions of its Advantix products off store shelves.

The settlement was reported by The Indiana Lawyer in May 2026, with the final defendant settlements finalized in March 2026 and Elanco's own settlement reached in February 2026. The litigation arose from two consolidated cases pending in the U.S. District Court for the Southern District of Indiana before Judge James Patrick Hanlon: Spradlin v. Elanco Animal Health, Inc., Case No. 1:24-cv-01299, filed July 2024, and a parallel case filed by consumer Susan Kraus-Silfen in January 2025 that added the five pet retailers as defendants.

Beyond the cash fund, the agreement bars Elanco from offering its exclusive Advantix discount to retailers for five years, which is the part of the deal aimed at opening the door for generic competitors to reach pet specialty store shelves.

Did You Buy K9 Advantix or Advantage From Chewy, Petco, PetSmart, PetMed Express, or Tractor Supply? 30-Second Self-Test

If you can answer yes to the question below, you may be a class member when the official notice is issued. The five named pet retailer defendants — Chewy (online), Petco, PetSmart, PetMed Express (online), and Tractor Supply / Petsense — are some of the largest pet specialty sellers in the U.S., so the qualifying buyer pool is expected to be broad.

• Did you buy K9 Advantix II or Advantage II (squeeze-on topical flea and tick treatment for dogs or cats) from Chewy, Petco, PetSmart, PetMed Express, or a Tractor Supply / Petsense store? The original complaint described a class of consumers who purchased topical flea and tick products containing imidacloprid from a pet specialty retailer over a multi-year window. The exact class definition and time period will be set out in the court-approved class notice when it is issued.

If you answered yes, save your receipts if you have them and watch for an email or postcard from the settlement administrator. Class notices typically arrive in the months following final court approval. OCA will update this page when the settlement administrator opens the official claim portal.

What Was the Elanco K9 Advantix Lawsuit About?

The lawsuit alleged a classic antitrust scheme: a manufacturer with dominant market share paid major retailers to refuse to stock cheaper generic competitors. The specifics are striking.

Elanco produces K9 Advantix II (for dogs) and Advantage II (for dogs and cats), squeeze-on topical flea and tick treatments whose active ingredient is imidacloprid. Elanco acquired the Advantix product line from Bayer in 2020 for $7.6 billion. The complaint alleged Elanco controlled approximately 85 percent of the U.S. imidacloprid topical market through direct sales and effectively close to 100 percent of the market when patent license royalties on authorized generics are counted.

The complaint alleged Elanco entered into verbal "no generics" agreements with Chewy, Petco, PetSmart, PetMed Express, and Petsense, offering increased profits through rebates, exclusive discounts, and bundled pricing on Elanco's blockbuster Seresto flea collar in exchange for the retailers refusing to carry generic imidacloprid topicals. The lawsuit detailed specific exchanges in which retailer representatives told a generic competitor (Tevra Brands) that they had agreements with Elanco (then Bayer) that prevented them from stocking competing imidacloprid products.

The price difference matters: per the complaint, a four-month supply of Tevra's generic Activate II sold for about $27 on Amazon, while a four-month supply of K9 Advantix II sold for about $54 on Chewy. For cat owners, a six-month supply of generic Actispot II sold for about $30 on Amazon, while a six-month supply of Advantage II for cats sold for about $64 on PetSmart. Despite that, none of the named pet specialty retailers carried any generic imidacloprid topicals.

Elanco has denied all allegations of wrongdoing and is settling without admitting liability.

The Path From Complaint to Settlement

For readers tracking how this case progressed, here is the timeline reconstructed from court records and clean news coverage.

• July 31, 2024: Tracy Spradlin, a Kansas resident, filed the original complaint in Spradlin v. Elanco Animal Health, Inc., Case No. 1:24-cv-01299, in the U.S. District Court for the Southern District of Indiana. The case named only Elanco as defendant and alleged violations of Sections 1 and 2 of the Sherman Act plus state antitrust laws of approximately 29 states and the District of Columbia.
• January 2025: A parallel case was filed by consumer Susan Kraus-Silfen against Elanco and the five pet retailers, raising similar federal antitrust violations and naming Chewy, Petco, PetSmart, PetMed Express, and Petsense as co-defendants.
• October 7, 2025: Judge James Patrick Hanlon granted in part and denied in part Elanco's motion to dismiss the Spradlin case. The federal Sherman Act claims were dismissed, but the state antitrust claims under the laws of approximately 29 states and the District of Columbia were allowed to proceed.
• January 2026: The court allowed the two cases to be consolidated into a single amended complaint joining the Spradlin and Kraus-Silfen claims.
• February 2026: Kraus-Silfen began reaching settlements one by one with defendants, starting with Chewy, then Tractor Supply/Petsense, then PetMed Express, then Elanco.
• March 2026: Final settlement reached with the remaining defendants, establishing the total fund at $9.275 million.
• May 2026: Settlement reported publicly. Next steps include preliminary court approval, class notice, and the opening of a settlement website with claim instructions.

What the $9.275M Settlement Provides

The headline figure is the $9,275,000 cash fund. Per The Indiana Lawyer reporting, the fund will be distributed to class members who file claims, after court approval of attorneys' fees, administrative expenses, and any class representative awards. Per-claimant payouts have not been announced and will depend on how many class members file claims and how the court allocates the fund.

Beyond the cash, the non-monetary relief is significant: Elanco is barred from offering its exclusive Advantix discount for five years. The complaint alleged that the exclusive discount was the core mechanism Elanco used to incentivize pet specialty retailers to refuse to stock generic competitors. Removing that discount from Elanco's toolkit for five years is intended to make it easier for generic imidacloprid topicals to reach pet specialty store shelves during that window. For pet owners, the practical consequence (if generics do reach the shelves) could be lower retail prices on imidacloprid flea and tick treatments over time.

When Will Elanco K9 Advantix Settlement Claim Forms Be Available? (Estimated Timeline)

No claim form, claim portal, or claim deadline has been published yet. The settlement is at the "settlement reached, awaiting court approval" stage, which in U.S. consumer class actions typically runs through several predictable steps before a claim form is publicly available. Below is OCA's best estimate based on typical class action settlement timelines — not an official schedule and subject to change once the court issues a preliminary approval order.

• Preliminary approval motion filed: estimated May to July 2026. Class counsel typically files the motion for preliminary approval shortly after executing the settlement agreement. Public docket activity in Spradlin v. Elanco Animal Health, Inc. (Case No. 1:24-cv-01299, S.D. Ind.) is the leading indicator.
• Preliminary approval order from Judge Hanlon: estimated summer to early fall 2026. Once the court approves the settlement preliminarily, the class notice plan and the settlement administrator are appointed.
• Class notice mailing / emailing begins: estimated 30 to 60 days after preliminary approval. Email notices are likely to go to Chewy, PetMed Express, Petco, PetSmart, and Tractor Supply / Petsense customers with on-file purchase history of K9 Advantix II or Advantage II. Postcard notices and a published-notice campaign in pet trade media are also typical.
• Official settlement website and online claim form open: estimated same day class notice begins. The notice itself routes claimants to the official settlement website with the claim portal, FAQs, and important documents.
• Claim filing window: typically 90 to 180 days from the start of notice. For an antitrust settlement of this size with five retailer defendants holding digital purchase records, expect at minimum a 120-day filing window.
• Final approval (fairness) hearing: estimated 4 to 6 months after preliminary approval — potentially late 2026 to early 2027.
• Payment distribution to approved claimants: typically 30 to 90 days after final approval becomes final, longer if any objector files an appeal. Realistically, first checks or digital payments could land spring or summer 2027 in a clean scenario.

Net of all that, the most likely public window for the claim form to actually open is late summer to fall 2026, with the claim deadline most likely landing late 2026 to early 2027. OCA will update this page the day the official claim portal goes live, including a direct link to the claim form, the verified deadline, and the per-claimant payout estimate once the court approves the plan of allocation.

Common Questions: Dogs vs Cats, In-Store vs Online, Seresto, and Generic Alternatives

Several recurring questions come up about who actually qualifies for the Elanco K9 Advantix settlement once the claim portal opens. The following points address the most common ones, based on the consolidated complaint and the public reporting on the settlement. The court-approved class notice will be the controlling document for class membership, payouts, and deadlines.

• Does the settlement cover both dogs and cats? The lawsuit covers both. K9 Advantix II is the dog-only line. Advantage II is sold for both dogs and cats. Both are squeeze-on topical imidacloprid products and both are within the alleged conduct.
• Does it cover online purchases (like Chewy and PetMed Express) or only in-store purchases? Both. All five retailer defendants — Chewy (online), PetMed Express (online), Petco (in-store and online), PetSmart (in-store and online), and Tractor Supply / Petsense (in-store and online) — are named in the consolidated case. Pet owners who bought through any channel of any of these five retailers are within the alleged class.
• Is Seresto flea collar covered? Seresto is referenced in the complaint as part of the alleged bundling and rebate conduct — Elanco allegedly conditioned exclusive Seresto discounts on retailers' agreement not to stock generic imidacloprid topicals — but Seresto itself is not the product class purchased class members are claiming on. The class purchase is K9 Advantix II and Advantage II.
• Does buying a generic like Tevra's Activate II or Actispot II disqualify me? No. The complaint actually identified Tevra's generics as the cheaper alternatives that Elanco allegedly kept off pet specialty store shelves. Buying a generic does not disqualify you from claiming on Advantix or Advantage purchases you also made from a named retailer.
• Which states are covered? The federal Sherman Act claims were dismissed in October 2025, so the case proceeded under the state antitrust laws of approximately 29 states and the District of Columbia. The exact list of covered states will be set out in the court-approved class notice. Pet owners in states whose antitrust laws were not part of the complaint may be excluded or placed in a different class for notice-only purposes.
• What time period is covered? The original Spradlin complaint described a multi-year purchase window stretching back several years before the July 2024 filing date. The exact start date and end date of the class period will be set out in the court-approved class notice.
• Do I need receipts to file a claim? Probably not for a basic claim, but receipts may unlock a higher payout tier. All five retailer defendants have substantial digital purchase records; Chewy and PetMed Express in particular track customer purchases in detail. Most class members are likely to be able to claim with no receipts and have the retailer verify the purchase from its records. Owners with receipts (paper or electronic) may qualify for a higher payment under the eventual plan of allocation.

What Pet Owners Should Do Right Now

With the settlement reached but the formal class notice not yet issued, pet owners who think they may be class members have a few practical steps available today.

• Save your receipts. If you have purchase records for K9 Advantix II or Advantage II from Chewy, Petco, PetSmart, PetMed Express, or a Tractor Supply or Petsense store, hold onto them. Antitrust settlements sometimes ask for proof of purchase to establish higher tiers of recovery, although many class members can claim without receipts if the retailer has the purchase on record.
• Check your email and physical mail. The five retailer defendants have digital purchase histories, especially Chewy and PetMed Express. The settlement administrator will likely email or mail notices to known purchasers using those records.
• Watch for the official settlement website. Class action settlements of this size always launch a dedicated settlement website with claim forms, eligibility details, and deadlines. Be cautious of unofficial copycat sites or scam emails asking for fees or sensitive information; legitimate class action settlements never require payment to participate.
• Bookmark OCA for updates. Once the official settlement website opens and class notice goes out, OCA will publish a dedicated settlements page with the claim form link, eligibility details, deadlines, and payout structure.

The Bigger Picture: Antitrust and Pet Medications

The Elanco settlement is part of a broader pattern of antitrust scrutiny in the pet medication industry. The Federal Trade Commission published a 2015 staff report, Competition in the Pet Medications Industry: Prescription Portability and Distribution Practices, which warned that manufacturers can wield "substantial influence over distributors that can be used to restrict generic manufacturers' access to distributors," and that "the absence of generic competition allows pioneer companies to continue to raise prices on and market drugs whose patents have expired."

The Spradlin complaint also referenced an earlier antitrust case, Tevra Brands, LLC v. Bayer Healthcare, LLC, filed in 2019, in which generic manufacturer Tevra Brands sued Bayer (Elanco's predecessor in the Advantix line) over essentially the same conduct alleged in the consumer case. Bayer sold the Advantix line to Elanco in 2020 as part of a $7.6 billion animal health division acquisition, which the FTC reviewed and approved subject to divestitures in other overlapping product areas.

For pet owners, the practical lesson is that brand-name dominance in any product category, including pet supplies, is sometimes maintained through retailer relationships rather than product superiority. Cheaper generic alternatives often exist; whether they reach store shelves depends on competition policy and litigation like this case.

Other Active Antitrust and Consumer Settlements

Antitrust class action settlements covering everyday consumer products, including pet supplies, electronics, financial services, and prescription medications, are common. Class members in one case may qualify for unrelated settlements covering different products; filing one claim does not affect eligibility for any others.

Check the OCA database of open class action settlements for other active cases and watch this page for an update once the official Elanco settlement website and claim form launch.

How Do I Find Class Action Settlements?

Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:

Original Class Action Complaint

Sources

• Spradlin v. Elanco Animal Health, Inc., Case No. 1:24-cv-01299-JPH-MKK, U.S. District Court for the Southern District of Indiana, Hon. James Patrick Hanlon presiding (Class Action Complaint filed July 31, 2024)
• The Indiana Lawyer, "Elanco reaches $9.3M settlement with consumers over antitrust allegations involving flea and tick products" (May 2026)
• PYMNTS.com, "Judge Limits Lawsuit Alleging Elanco Monopolized Pet Medication Market" (October 2025)
• Bloomberg Law, "Elanco Escapes Some, but Not All, Claims in Animal Products Suit" (October 2025)
• CourtListener docket: Spradlin v. Elanco Animal Health, Inc., 1:24-cv-01299 (S.D. Ind.)
• Federal Trade Commission, Competition in the Pet Medications Industry: Prescription Portability and Distribution Practices (May 2015)

About OCA News Coverage

This article is general news reporting about an antitrust class action settlement, not legal advice. OpenClassActions.com is a consumer news site and is not the Settlement Administrator or a law firm; we do not process or decide claims. Per-class member payouts, claim deadlines, and the official settlement website have not been announced as of publication and will be added to this page when they are released.

For more class actions keep scrolling below.

Open Class Action Lawsuit and Class Action Settlement

Social Media Addiction Cases - Prequalify

Status: Open

Pre-Qualify

DraftKings & FanDuel Addiction Lawsuits

Status: Open

Learn More

Roblox - Investigation

Pre-Qualify Here

Submit Claim

File a rebate form to get a coupon, refund, rebate, or payment from this new class action settlement

$68M Google Assistant Settlement

Deadline: August 27, 2026

Submit Claim

$87.5M Beef Prices Settlement

Deadline: June 30, 2026

Submit Claim

Elanco Pet Antitrust Settlement Snapshot
Status	Settlement Reached March 2026 — Class Notice Pending
Total Settlement Fund	$9.275 million (combined Elanco + five retailer settlements)
Non-Monetary Relief	Elanco barred from offering its exclusive Advantix discount for five years
Per-Claimant Payout	Not yet announced; will be set after court approval of fees and administrative costs
Affected Products	Elanco K9 Advantix II (for dogs) and Advantage II (for dogs and cats), squeeze-on topical imidacloprid flea and tick treatments
Defendant Manufacturer	Elanco Animal Health, Inc. (acquired the Advantix line from Bayer in 2020 for $7.6 billion)
Defendant Retailers	Chewy Inc.; Petco Animal Supplies Store Inc.; PetSmart LLC; PetMed Express Inc.; Petsense LLC (owned by Tractor Supply Co.)
Cases Consolidated	Spradlin v. Elanco (Case No. 1:24-cv-01299, S.D. Ind., filed July 2024) and a Kraus-Silfen action (filed January 2025)
Court	U.S. District Court for the Southern District of Indiana
Judge	Hon. James Patrick Hanlon
Legal Claims	Federal Sherman Act Sections 1 and 2 (dismissed at motion to dismiss stage in October 2025); state antitrust laws of approximately 29 states and the District of Columbia (proceeded)
Allegations	Elanco allegedly entered into verbal "no generics" agreements with pet specialty retailers, paying or rewarding them to refuse generic imidacloprid alternatives like Tevra's Activate II and Actispot II, keeping retail prices supracompetitive
Class Representatives	Tracy Spradlin (Kansas); Susan Kraus-Silfen
Estimated Claim Form Open	Late Summer to Fall 2026 (OCA estimate — not an official date)
Estimated Claim Deadline	Late 2026 to Early 2027 (typical 90–180 day window after class notice)
Estimated First Payments	Spring to Summer 2027 (assumes no appeals; 30–90 days after final approval)
Watch For	Official class notice and settlement website launch in the months following preliminary court approval
Browse Settlements	OCA Open Settlements Database